Literature DB >> 10230831

Selection bias and the use of controls with malformations in case-control studies of birth defects.

S Lieff1, A F Olshan, M Werler, D A Savitz, A A Mitchell.   

Abstract

We compared four methods of control selection to assess the effect of using infants with malformations as controls in case-control studies of birth defects. We identified cases and controls using data from the Slone Epidemiology Unit Births Defect Study for the years 1976-1992. Cases were defined as infants with cleft lip and palate and no other malformations (N = 494). Controls (N = 8356) were chosen from infants with other malformations, excluding other oral cleft conditions or syndromes associated with clefts. Maternal smoking during the first 13 weeks of pregnancy was the exposure of interest. We then assessed the measures of association resulting from using controls with varying restrictions. When we excluded all defects potentially associated with maternal smoking (based on reports in the literature), the crude odds ratio for smoking and oral cleft risk was 1.6 (1.3-1.9). When we eliminated all defect groups with a smoking prevalence that was one or more standard deviations above or below the total control group mean, the odds ratio was 1.5 (1.2-1.8); with controls restricted to infants with Mendelian-inherited disorders (with presumably no causal effect of smoking), the odds ratio was 1.6 (1.1-2.7); and when selection was unrestricted, the crude odds ratio was 1.5 (1.2-1.8). When used selectively, infants with malformations other than the anomaly of interest can be a suitable source of controls.

Entities:  

Mesh:

Year:  1999        PMID: 10230831

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  8 in total

1.  Response to: Case-control studies require appropriate population controls: an example of error in the SSRI birth defect literature.

Authors:  Helen Dolk; Anthony Wemakor
Journal:  Eur J Epidemiol       Date:  2015-11-30       Impact factor: 8.082

2.  The risk for four specific congenital heart defects associated with assisted reproductive techniques: a population-based evaluation.

Authors:  Karim Tararbit; Nathalie Lelong; Anne-Claire Thieulin; Lucile Houyel; Damien Bonnet; François Goffinet; Babak Khoshnood
Journal:  Hum Reprod       Date:  2012-11-22       Impact factor: 6.918

3.  Maternal recall of prescription medication use during pregnancy using a paper-based questionnaire: a validation study in the Netherlands.

Authors:  Marleen M H J van Gelder; Iris A L M van Rooij; Hermien E K de Walle; Nel Roeleveld; Marian K Bakker
Journal:  Drug Saf       Date:  2013-01       Impact factor: 5.606

4.  Adjusting for bias due to incomplete case ascertainment in case-control studies of birth defects.

Authors:  Penelope P Howards; Candice Y Johnson; Margaret A Honein; W Dana Flanders
Journal:  Am J Epidemiol       Date:  2015-03-19       Impact factor: 4.897

5.  Advances in medical technology and creation of disparities: the case of Down syndrome.

Authors:  Babak Khoshnood; Catherine De Vigan; Véronique Vodovar; Gérard Bréart; François Goffinet; Béatrice Blondel
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

6.  Risk of hypospadias in relation to maternal occupational exposure to potential endocrine disrupting chemicals.

Authors:  M Vrijheid; B Armstrong; H Dolk; M van Tongeren; B Botting
Journal:  Occup Environ Med       Date:  2003-08       Impact factor: 4.402

7.  Maternal risk factors for the VACTERL association: A EUROCAT case-control study.

Authors:  Romy van de Putte; Iris A L M van Rooij; Cynthia P Haanappel; Carlo L M Marcelis; Han G Brunner; Marie-Claude Addor; Clara Cavero-Carbonell; Carlos M Dias; Elizabeth S Draper; Larraitz Etxebarriarteun; Miriam Gatt; Babak Khoshnood; Agnieszka Kinsner-Ovaskainen; Kari Klungsoyr; Jenny J Kurinczuk; Anna Latos-Bielenska; Karen Luyt; Mary T O'Mahony; Nicola Miller; Carmel Mullaney; Vera Nelen; Amanda J Neville; Isabelle Perthus; Anna Pierini; Hanitra Randrianaivo; Judith Rankin; Anke Rissmann; Florence Rouget; Bruno Schaub; David Tucker; Diana Wellesley; Awi Wiesel; Natalya Zymak-Zakutnia; Maria Loane; Ingeborg Barisic; Hermien E K de Walle; Jorieke E H Bergman; Nel Roeleveld
Journal:  Birth Defects Res       Date:  2020-04-22       Impact factor: 2.344

8.  Metformin exposure in first trimester of pregnancy and risk of all or specific congenital anomalies: exploratory case-control study.

Authors:  Joanne E Given; Maria Loane; Ester Garne; Marie-Claude Addor; Marian Bakker; Bénédicte Bertaut-Nativel; Miriam Gatt; Kari Klungsoyr; Nathalie Lelong; Margery Morgan; Amanda J Neville; Anna Pierini; Anke Rissmann; Helen Dolk
Journal:  BMJ       Date:  2018-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.